Quality control covers incoming material verification, in‑process sampling and finished‑product release testing. Our analytical lab is equipped with HPLC, GC, chiral chromatography and moisture detection instruments. Each batch of statin, SGLT‑2 inhibitor and oncology intermediate passes full‑item inspection before release, blocking non‑conforming materials from downstream usage.
Every incoming batch undergoes identity confirmation, purity screening, and CoA cross-validation before warehouse acceptance.
DCS-linked automated sampling at critical control points with real-time deviation alerts and corrective action triggers.
Comprehensive quality verification including assay, impurity profile, and physical properties against specification limits.
Complete batch records, CoA generation, and chain-of-custody documentation enabling full traceability and controlled release.
Quality assurance builds a preventive system beyond end‑point testing. QA teams review process validation protocols, monitor deviation handling and approve change controls. We conduct periodic stability studies and supplier qualification reviews. The system safeguards that production conditions, analytical methods and documentation stay aligned with defined quality targets long term.
Every production batch undergoes comprehensive quality verification before release.
Continuous process monitoring with automated deviation alerts and corrections.
Multi-layered quality control ensuring zero critical defects reach customers.
Complete batch documentation enabling full traceability from raw material to delivery.